Tuesday, April 2, 2019

Zydus Cadila gets tentative USFDA nod for overactive bladder treatment drug

Zydus Cadila gets tentative USFDA nod for overactive bladder treatment drug The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Mirabegron extended-release tablets in the strengths of 25 mg and 50 mg, Zydus Cadila said in a statement.

from Moneycontrol Business News https://ift.tt/2VbmuiT
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...